GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GtreeBNT Co Ltd (115450) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9385
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epidermolysis bullosa dermal disease. GtreeBNT offers OKN-007 for the treatment of glioblastoma brain cancer. It also produces pumps, motors, fan motors, and transformers. The company plans to conduct clinical trials in South Korea and the US. It operates offices in Seongnam and Chilgok, South Korea. GtreeBNT is headquartered in Seongnam, South Korea.

GtreeBNT Co Ltd (115450) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
Venture Financing 11
G-treeBNT Raises USD1.4 Million in Venture Financing 11
Partnerships 12
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
Licensing Agreements 14
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
Equity Offering 16
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd – Key Competitors 19
GtreeBNT Co Ltd – Key Employees 20
GtreeBNT Co Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
G-treeBNT Raises USD1.4 Million in Venture Financing 11
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd, Key Competitors 19
GtreeBNT Co Ltd, Key Employees 20
GtreeBNT Co Ltd, Other Locations 21
GtreeBNT Co Ltd, Subsidiaries 21
GtreeBNT Co Ltd, Joint Venture 21

List of Figures
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln Pharmaceuticals Ltd (LINCOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lincoln Pharmaceuticals Ltd (Lincoln Pharmaceuticals) manufactures, markets and exports pharmaceutical products. The company provides pharmaceuticals for cardiovascular, central nervous system, dermatology and ear nose throat disorders; gastrointestinal and genitourinary infections; hematolo …
  • Formosa Petrochemical Corp (6505):石油・ガス:M&Aディール及び事業提携情報
    Summary Formosa Petrochemical Corp (FPCC) refines crude oil and sells refined petroleum products and olefins. The company operates refinery and integrated petrochemical complexes. It imports, exports, markets, stores, and transports crude oil, gasoline, naphtha, propane and other feed stocks. The co …
  • Portland General Electric Co (POR):電力:M&Aディール及び事業提携情報
    Summary Portland General Electric Co (PGE) is a vertically integrated electric utility that generates, transmits, distributes, and retails electricity. The company generates electricity from wholly and jointly owned wind, natural gas, coal and hydroelectric plants. PGE also participates in the whole …
  • Sika Interplant Systems Limited:企業の戦略・SWOT・財務分析
    Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report Summary Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cleco Corporate Holdings LLC:発電所・企業SWOT分析
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Copper Mountain Mining Corporation:企業の戦略・SWOT・財務情報
    Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Cardiovascular Systems Inc (CSII):製品パイプライン分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessorie …
  • PGE Polska Grupa Energetyczna SA (PGE):電力:M&Aディール及び事業提携情報
    Summary PGE Polska Grupa Energetyczna SA (PGE SA) is a state owned energy utility. It generates, trades, transmits, and distributes electricity. The company carries out lignite mining activities, electricity generation from fossil fuels (lignite, hard coal, and natural gas) and renewable energy sour …
  • Arthrex Inc:医療機器:M&Aディール及び事業提携情報
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company that designs and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and wr …
  • Proteus Digital Health Inc:企業の戦略的SWOT分析
    Proteus Digital Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Merrimack Pharmaceuticals Inc (MACK):企業の財務・戦略的SWOT分析
    Merrimack Pharmaceuticals Inc (MACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pro-Dex Inc (PDEX):製品パイプライン分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Chesapeake Utilities Corp (CPK):企業の財務・戦略的SWOT分析
    Summary Chesapeake Utilities Corp (Chesapeake), a subsidiary of Chesapeake Energy Corp is a utility service provider that markets and distributes natural gas. The utility transmits, distributes, and markets propane, electricity, and natural gas. It also provides online bill payment, energy conservat …
  • Theralase Technologies Inc (TLT):製品パイプライン分析
    Summary Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such as controller, multiple probe, triple probe, single probe, multiple p …
  • Ansaldo STS SpA:企業の戦略・SWOT・財務情報
    Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report Summary Ansaldo STS SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Energy Development Corporation (EDC):企業の財務・戦略的SWOT分析
    Energy Development Corporation (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Cafe De Coral Holdings Limited:企業の戦略・SWOT・財務分析
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Eurofins Scientific SE (ERF):製薬・医療:M&Aディール及び事業提携情報
    Summary Eurofins Scientific SE (Eurofins) is a life sciences company, which provides a range of analytical testing services to clients in various industries. The company offers food and feed testing, biopharma services, pharma discovery services, genomic pharma services, pharma early development, ph …
  • ConocoPhillips (COP)-エネルギー分野:企業M&A・提携分析
    Summary ConocoPhillips is an independent upstream oil and gas company. The company explore for, produce, transport and market crude oil, bitumen, natural gas, liquefied natural gas (LNG) and natural gas liquids across the world. It has assets across North America, Europe, Asia and Australia. Its ass …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆